NRT Smoking Cessation Aids in France

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN FRANCE
• France: A Relatively Small Market
• the Unexpected Consequences of De-reimbursement
• OTC Analgesics Manufacturers Lead the Market
• Pharmacies: the Main Distribution Channel
• the Development of OTC Healthcare in France
• De-reimbursement and Consumers' Misunderstanding
• OTC Available on A Self-service Basis - A Step Further To the Anglo-saxon Model
• A New Healthcare System in France?
• Self-medication and Changing Mentalities
• An Increased Need for Nutritional Products and Smoking Cessation Aids
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
  • Table 2 Life Expectancy at Birth 2002-2007
  • Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
  • Table 5 OTC Healthcare Company Shares by Value 2003-2007
  • Table 6 OTC Healthcare Brand Shares by Value 2004-2007
  • Table 7 Penetration of Private Label by Sector 2003-2007
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
• OTC Registration and Classification
• Advertising
• Packaging and Labelling
• Distribution
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Switches
  • Summary 1 Rx-to-OTC Healthcare Switches 2006-2008
  • Summary 2 Research Sources
• LOCAL COMPANY PROFILES - FRANCE
• Arkopharma Sa, Laboratoires Pharmaceutiques
  • Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts
  • Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators
  • Summary 5 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2007
• Beaufour-ipsen SA
  • Summary 6 Beaufour-Ipsen SA: Key Facts
  • Summary 7 Beaufour-Ipsen SA: Operational Indicators
  • Summary 8 Beaufour-Ipsen SA: Production Statistics 2006
  • Summary 9 Beaufour-Ipsen SA: Competitive Position 2007
• GlaxoSmithKline Sante Grand Public Sas
  • Summary 10 GlaxoSmithKline Sante Grand Public SAS: Key Facts
  • Summary 11 GlaxoSmithKline Sante Grand Public SAS: Operational Indicators
  • Summary 12 GlaxoSmithKline: Production Statistics 2007
  • Summary 13 GlaxoSmithKline Sante Grand Public SAS: Competitive Position 2007
• Juva Sante, Laboratoires
  • Summary 14 Juva Sante, Laboratoires: Key Facts
  • Summary 15 Juva Sante, Laboratoires: Operational Indicators
  • Summary 16 Juva Sante, Laboratoires: Production Statistics
  • Summary 17 Juva Sante, Laboratoires: Competitive Position 2007
• Laboratoires Martin-johnson & Johnson-msd Sas
  • Summary 18 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts
  • Summary 19 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators
  • Summary 20 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2007
• Pfizer Sante Grand Public
  • Summary 21 Pfizer Sante Grand Public: Key Facts
  • Summary 22 Pfizer Sante Grand Public: Operational Indicators
  • Summary 23 Pfizer Sante Grand Public: Competitive Position 2007
• Pierre Fabre Sa, Laboratoires
  • Summary 24 Pierre Fabre SA, Laboratoires: Key Facts
  • Summary 25 Pierre Fabre SA, Laboratoires: Operational Indicators
  • Summary 26 Pierre Fabre SA, Laboratoires: Production Statistics 2006-2007
  • Summary 27 Pierre Fabre SA, Laboratoires: Competitive Position 2007
• Theraplix SA
  • Summary 28 Theraplix SA: Key Facts
  • Summary 29 Theraplix SA: Operational Indicators
  • Summary 30 Theraplix SA: Competitive Position 2007
• Upsa, Laboratoires
  • Summary 31 UPSA Conseil SAS: Key Facts
  • Summary 32 UPSA Conseil SAS: Operational Indicators
  • Summary 33 UPSA Conseil SAS: Production Statistics
  • Summary 34 UPSA, Laboratoires: Competitive Position 2007
• Urgo, Laboratoires
  • Summary 35 Urgo, Laboratoires: Key Facts
  • Summary 36 Urgo, Laboratoires: Operational Indicators
  • Summary 37 Urgo, Laboratoires: Competitive Position 2007
• NRT SMOKING CESSATION AIDS IN FRANCE
  • Table 12 Number of Smokers by Gender 2002-2007
  • Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007
  • Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007
  • Table 15 NRT Gum Flavours 2006-2007
  • Table 16 Smoking Cessation Aids Company Shares by Value 2003-2007
  • Table 17 Smoking Cessation Aids Brand Shares by Value 2004-2007
  • Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012
  • Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012
• NRT Smoking cessation aids France